Search Results - "Okello, Aren"
-
1
An early and late peak in microglial activation in Alzheimer's disease trajectory
Published in Brain (London, England : 1878) (01-03-2017)“…Amyloid-β deposition, neuroinflammation and tau tangle formation all play a significant role in Alzheimer's disease. We hypothesized that there is microglial…”
Get full text
Journal Article -
2
Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease
Published in Brain (London, England : 1878) (01-12-2015)“…Amyloid deposition, tangle formation, neuroinflammation and neuronal dysfunction are pathological processes involved in Alzheimer's disease. However, the…”
Get full text
Journal Article -
3
Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers
Published in Brain (London, England : 1878) (01-01-2011)“…(11)Carbon-Pittsburgh compound B positron emission tomography studies have suggested early and prominent amyloid deposition in the striatum in presenilin 1…”
Get full text
Journal Article -
4
A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
Published in European journal of nuclear medicine and molecular imaging (2013)Get full text
Journal Article -
5
A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
Published in European journal of nuclear medicine and molecular imaging (2013)“…Purpose Amyloid PET tracers have been developed for in vivo detection of brain fibrillar amyloid deposition in Alzheimer’s disease (AD). To serve as an early…”
Get full text
Journal Article -
6
P1‐283: An Early and Late Peak in Microglial Activation in Alzheimer’s Disease Trajectory: A Longitudinal Pet Study
Published in Alzheimer's & dementia (01-07-2016)Get full text
Journal Article -
7
ANALYSIS OF AN ADULT DUCHENNE MUSCULAR DYSTROPHY POPULATION: TEN YEARS ON
Published in Journal of neurology, neurosurgery and psychiatry (01-11-2015)“…BackgroundDuchenne muscular dystrophy (DMD) is a progressive, multi-systemic condition, management of which has benefitted from improvements in research and…”
Get full text
Journal Article -
8
AN EARLY AND LATE PEAK IN MICROGLIAL ACTIVATION IN ALZHEIMER’S DISEASE TRAJECTORY: A LONGITUDINAL PET STUDY
Published in Alzheimer's & dementia (01-07-2016)Get full text
Journal Article -
9
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Published in Lancet neurology (01-04-2010)“…Carbon-11-labelled Pittsburgh compound B ( 11C-PiB) PET is a marker of cortical fibrillar amyloid-β load in vivo. We used 11C-PiB PET to investigate whether…”
Get full text
Journal Article -
10
sup 11^C-PiB PET assessment of change in fibrillar amyloid-[beta] load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Published in Lancet neurology (01-04-2010)“…Carbon-11-labelled Pittsburgh compound B ((11)C-PiB) PET is a marker of cortical fibrillar amyloid-beta load in vivo. We used (11)C-PiB PET to investigate…”
Get full text
Journal Article -
11
super(11)C-PiB PET assessment of change in fibrillar amyloid- beta load in patients with Alzheimer' s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Published in Lancet neurology (01-04-2010)“…Carbon-11-labelled Pittsburgh compound B ( super(11)C-PiB) PET is a marker of cortical fibrillar amyloid- beta load in vivo. We used super(11)C-PiB PET to…”
Get full text
Journal Article -
12
O3‐06‐03: Early subcortical amyloid deposition in familial Alzheimer's disease is accompanied by changes in tissue volume and diffusivity
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
13
11 C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Published in Lancet neurology (2010)“…Summary Background Carbon-11-labelled Pittsburgh compound B (11 C-PiB) PET is a marker of cortical fibrillar amyloid-β load in vivo. We used11 C-PiB PET to…”
Get full text
Journal Article -
14
Pet studies on disease progression and treatment efficacy in alzheimer's disease and mild cognitive impairment
Published 01-01-2011“…Alzheimer’s disease (AD) is the most common cause of dementia. Mild cognitive impairment (MCI) is a transitional state between normal ageing and dementia…”
Get full text
Dissertation -
15
Early subcortical amyloid deposition in familial Alzheimer's disease is accompanied by changes in tissue volume and diffusivity
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
16
-
17
-
18
O3-06-05: Amyloid deposition and cerebral glucose metabolism in Alzheimer’s disease: A longitudinal 11C-PIB and 18F-FDG PET study
Published in Alzheimer's & dementia (01-07-2006)Get full text
Journal Article -
19
O3–06–05: Amyloid deposition and cerebral glucose metabolism in Alzheimer's disease: A longitudinal 11 C–PIB and 18 F–FDG PET study
Published in Alzheimer's & dementia (01-07-2006)Get full text
Journal Article -
20
P2–120: Amyloid deposition and cerebral glucose metabolism in mild cognitive impairment : A longitudinal 11 C–PIB and 18 F–FDG PET study
Published in Alzheimer's & dementia (01-07-2006)Get full text
Journal Article